Company Report
Last edited 5 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#25
Performance (40m)
-18.2% pa
Followed by
21
Price History

Premium Content

Last edited 5 months ago
Valuation

Premium Content

Notes

Premium Content

Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Eurosatory 2024
Added 5 months ago
#Bull Case
stale
Last edited 10 months ago

The buyers side is not dropping away and investors are lining up to get in.

The market was possibly waiting for evidence of what the company could achieve. Its latest results show / suggest they are no longer just talking about potential sales but actually making sales and demand is increasing.

I can’t help but think this has more to run considering the industry tail winds and evidence of execution. Of course for traders opportunities may present as it’s only wishful thinking this is going up in a straight line…though it would be nice…ha ha.

With a target of 300-500m in revenue within 5 years I would think this 400m MC will be much higher come years end. Let’s see.

As a holder it’s nice to see a stock run on actual fundamentals. I think it’s a great example of those stocks that Andrew mentions have a price miss-match. So when the market does take notice (wakes up) they can run.

In saying all of this it definitely seems to be one of the “it’s hot to own stocks” so I am sure there is some FOMO also backed in, but then again how many of us said that about Promedicus? Just look at it now!!